KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Astrazeneca (AZN) Other Non-Current Assets (2016 - 2025)

Astrazeneca has reported Other Non-Current Assets over the past 10 years, most recently at $559.0 million for Q4 2025.

  • For Q4 2025, Other Non-Current Assets rose 57.02% year-over-year to $559.0 million; the TTM value through Dec 2025 reached $559.0 million, up 57.02%, while the annual FY2025 figure was $559.0 million, 57.02% up from the prior year.
  • Other Non-Current Assets for Q4 2025 was $559.0 million at Astrazeneca, up from $356.0 million in the prior quarter.
  • Over five years, Other Non-Current Assets peaked at $559.0 million in Q4 2025 and troughed at $243.0 million in Q4 2022.
  • A 5-year average of $378.3 million and a median of $373.5 million in 2021 define the central range for Other Non-Current Assets.
  • Biggest five-year swings in Other Non-Current Assets: soared 357.47% in 2021 and later tumbled 37.85% in 2022.
  • Year by year, Other Non-Current Assets stood at $391.0 million in 2021, then plummeted by 37.85% to $243.0 million in 2022, then rose by 12.76% to $274.0 million in 2023, then rose by 29.93% to $356.0 million in 2024, then skyrocketed by 57.02% to $559.0 million in 2025.
  • Business Quant data shows Other Non-Current Assets for AZN at $559.0 million in Q4 2025, $356.0 million in Q4 2024, and $274.0 million in Q4 2023.